ArticleBioImpacts : BI2026

Targeted delivery of doxorubicin using RSV F-protein modified breast cancer-derived exosomes in breast cancer-bearing mice.

Narges Mardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.